Chih-ping Han
Taitung, TNQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
HER2 mutation profiling in mucinous ovarian carcinoma: Inferences for Enhertu (trastuzumab deruxtecan) as a potential therapeutic approach.
Journal: Taiwanese journal of obstetrics & gynecology
Published: April 24, 2025
Profiling of HER2, KRAS, and PIK3CA mutations in uterine cervical neuroendocrine carcinoma and implications for oncogenic driver targeting therapy.
Journal: Cancer genetics
Published: April 20, 2025
High frequency of BRAF mutations and concomitant KRAS mutations in Taiwanese ovarian clear cell carcinoma.
Journal: Taiwanese journal of obstetrics & gynecology
Published: December 23, 2024
HER2 mutations in advanced cervical neuroendocrine carcinoma: implications for trastuzumab deruxtecan therapy.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: February 20, 2024
Mutational analysis of PDGFRA oncogene in high-grade neuroendocrine carcinoma of the uterine cervix in twelve Taiwanese women.
Journal: Taiwanese journal of obstetrics & gynecology
Published: November 01, 2023
The status of KRAS mutations in primary ovarian clear cell carcinoma: An analysis of 17 Taiwanese patients.
Journal: Taiwanese journal of obstetrics & gynecology
Published: January 09, 2023
Both Kras gene mutation and Her2 gene mutation tend to exist in an inverse manner but not mutually exclusive in mucinous ovarian carcinoma: An analysis of 21 taiwanese women.
Journal: Journal of cancer research and therapeutics
Published: July 28, 2022
Absence of PIK3CA mutation in primary mucinous ovarian carcinoma: An analysis of 20 Taiwanese cases by FemtoPath PIK3CA mutation screen kit.
Journal: Taiwanese journal of obstetrics & gynecology
Published: February 07, 2022
Comparing the 2017 ASCO/CAP guideline for gastroesophageal adenocarcinoma surgical specimen to the 2018 ASCO/CAP guideline for breast cancer in assessing the HER2 status in primary mucinous ovarian carcinoma.
Journal: Virchows Archiv : an international journal of pathology
Published: October 25, 2021
High frequency of BRAF mutations in primary mucinous ovarian carcinoma of Taiwanese patients.
Journal: Taiwanese journal of obstetrics & gynecology
Published: May 26, 2021
The Her2 gene aberrations in mucinous ovarian carcinoma: Analysis of twenty-one cases.
Journal: Taiwanese journal of obstetrics & gynecology
Published: May 22, 2019
Molecular profiling of c-KIT oncogene in high grade neuroendocrine carcinoma of the uterine cervix: Analysis of twelve cases.
Journal: Taiwanese journal of obstetrics & gynecology
Published: November 25, 2018
Last Updated: 09/26/2026